Season’s Greetings!  A very warm welcome to the end of the year round-up edition of our newsletter.

As 2022 draws to a close, we reflect on our highlight news from the past twelve months, and some very significant and exciting changes here at pharmasol – led, of course, by our merger with PharmaLex, which we announced back in February. 

We hope you enjoy this special round-up issue, which offers a summary of all our major company developments throughout the year, plus stories and features you may have missed.

We’ll be sending out our full Winter edition of our quarterly newsletter early in the New Year, with a look ahead to some exciting developments coming in 2023 that you won’t want to miss, so do look out for it in your inbox.

If you’d like to make a positive start to January by meeting with the pharmasol team and discovering how we can help with any of your PV needs, as always, please just get in touch with us.

In the meantime, from everyone here at pharmasol, we’d like to wish you and your families a peaceful and happy holiday season, and we look forward to connecting with you in the New Year.

Best regards,

Tim Billington
Chief Sales Officer
+44 118 328 2629
tim.billington@pharmasol.de

NEWS ROUND-UP 2022:

FEBRUARY: Kicking off the year, we announced our big news – the completion of our merger with PharmaLex, one of the world’s largest providers of specialised services for the pharma, biotech and medtech industries. This successful strategic consolidation has brought to the PharmaLex Group our industry-leading SUSAR distribution platform, psiXchange, plus our growing portfolio of full-service pharmacovigilance business support capabilities – boosting the solution footprint of PharmaLex’s established Technology-Enabled Smart Services (TESS) division. 

Catch up on the press announcement here.

MARCH: In March, pharmasol issued the very first edition of our new quarterly customer newsletter, packed with news, views and a round-up of recent press articles and interviews.

Click here for the Spring issue.

APRIL: April saw us sharing the story of how our rapidLIVE accelerated pre-packaged implementation for Oracle Argus Safety is transforming case processing efficiency for award-winning PV service provider IntuVigilance. Download the case study now.

MAY: In May, pharmasol was delighted to co-host an exclusive webinar with Oracle Health Sciences, exploring how pharmasol’s accelerated SaaS deployment for Oracle Argus Safety – rapidLIVE – is helping small and mid-size pharmaceutical companies and CROs implement Oracle’s class-leading PV database in the most efficient and cost-effective way. This popular webinar demonstrated how rapidLIVE makes Argus accessible to all businesses – whatever your company size or budget.

If you’d like to access an on-demand version of this online session – which featured live contributions from pharmasol’s PV experts plus customer perspectives – please get in touch.

JULY: The Summer edition of our newsletter brought the news that our rapidLIVE accelerated deployment solution for Oracle Argus Safety has now been updated to Oracle Argus Release 8.2.3.1, plus offers an exciting look-ahead to psiXchange 2.4.1.

This issue also featured news of another landmark PharmaLex industry move – its merger with leading electronic Trial Master File (TMF) player Phlexglobal.

Read the issue here.

SEPTEMBER: Our Autumn newsletter delivered an extra special roadmap update, with pharmasol’s CEO Torsten Adam and Product Owner for psiXchange Karin van Dort giving an exclusive sneak-peek at the enhanced functionality and major performance updates users can expect from psiXchange version 3.0 when it hits the market in 2023.

In another milestone industry move, leading global healthcare company AmerisourceBergen Corporation (NYSE: ABC) announced that it has signed a definitive agreement to acquire PharmaLex Holding GmbH. This acquisition of the consolidated Group by AmerisourceBergen is set to further boost the global footprints and capabilities of both organisations. Read the official press announcement here.

In September, the pharmasol team hit the road with a presence at two major European conferences, in a very welcome return to in-person events. At a busy PIPA Conference 2022 in Farnham, UK, pharmasol was represented by our IT Director Iain Barnden, while at World Drug Safety Congress Europe in Amsterdam, Karin van Dort delivered a well-received keynote presentation outlining how organisations can boost efficiency and compliance while lowering costs through safety reporting automation.

NOVEMBER: Our latest success story explores how Clinical Research Organisation Drug Safety Navigator is gaining from rapidLIVE’s streamlined flexibility. Download the .pdf or read it online here.

Happy holidays and see you in 2023!